Small-molecule inhibitors targeting prostate-specific membrane antigen (PSMA) have demonstrated promising results in the theranostics of prostate cancer (PCa).
We designed and synthesized a novel small-molecule PSMA inhibitor, SC691.
This study aimed to conduct a preliminary clinical prospective investigation of
